These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


89 related items for PubMed ID: 24030986

  • 1. Translating antibody insights.
    Gerberding JL.
    Science; 2013 Sep 13; 341(6151):1151. PubMed ID: 24030986
    [No Abstract] [Full Text] [Related]

  • 2. Antibodies, viruses and vaccines.
    Burton DR.
    Nat Rev Immunol; 2002 Sep 13; 2(9):706-13. PubMed ID: 12209139
    [Abstract] [Full Text] [Related]

  • 3. Editorial overview: Preventive and therapeutic vaccines (B cell epitope vaccine).
    Law M.
    Curr Opin Virol; 2015 Apr 13; 11():viii-x. PubMed ID: 26003398
    [No Abstract] [Full Text] [Related]

  • 4. AIDS/HIV. A boost for HIV vaccine design.
    Burton DR, Weiss RA.
    Science; 2010 Aug 13; 329(5993):770-3. PubMed ID: 20705840
    [No Abstract] [Full Text] [Related]

  • 5. Super antibody may have the potential to both prevent and cure flu.
    Breeze S.
    Immunotherapy; 2012 Nov 13; 4(11):1093-4. PubMed ID: 23326919
    [No Abstract] [Full Text] [Related]

  • 6. Partial protection against classical swine fever virus elicited by dendrimeric vaccine-candidate peptides in domestic pigs.
    Tarradas J, Monsó M, Muñoz M, Rosell R, Fraile L, Frías MT, Domingo M, Andreu D, Sobrino F, Ganges L.
    Vaccine; 2011 Jun 10; 29(26):4422-9. PubMed ID: 21496472
    [Abstract] [Full Text] [Related]

  • 7. Strategies to guide the antibody affinity maturation process.
    Doria-Rose NA, Joyce MG.
    Curr Opin Virol; 2015 Apr 10; 11():137-47. PubMed ID: 25913818
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Developments in virus-like particle-based vaccines for infectious diseases and cancer.
    Buonaguro L, Tagliamonte M, Tornesello ML, Buonaguro FM.
    Expert Rev Vaccines; 2011 Nov 10; 10(11):1569-83. PubMed ID: 22043956
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immunization of macaques with soluble HIV type 1 and influenza virus envelope glycoproteins results in a similarly rapid contraction of peripheral B-cell responses after boosting.
    Sundling C, Martinez P, Soldemo M, Spångberg M, Bengtsson KL, Stertman L, Forsell MN, Karlsson Hedestam GB.
    J Infect Dis; 2013 Feb 01; 207(3):426-31. PubMed ID: 23162135
    [Abstract] [Full Text] [Related]

  • 13. GP4-specific neutralizing antibodies might be a driving force in PRRSV evolution.
    Costers S, Vanhee M, Van Breedam W, Van Doorsselaere J, Geldhof M, Nauwynck HJ.
    Virus Res; 2010 Dec 01; 154(1-2):104-13. PubMed ID: 20837070
    [Abstract] [Full Text] [Related]

  • 14. [Current vaccination strategies].
    Dietz K.
    Internist (Berl); 1992 Sep 01; 33(9):575-80. PubMed ID: 1399392
    [No Abstract] [Full Text] [Related]

  • 15. A peptide encoding a B-cell epitope from the N-terminus of the capsid protein L2 of bovine papillomavirus-4 prevents disease.
    Campo MS, O'Neil BW, Grindlay GJ, Curtis F, Knowles G, Chandrachud L.
    Virology; 1997 Aug 04; 234(2):261-6. PubMed ID: 9268157
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Keeping the memory of influenza viruses.
    Combadière B, Sibéril S, Duffy D.
    Pathol Biol (Paris); 2010 Apr 04; 58(2):e79-86. PubMed ID: 20303671
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Passive immunotherapy of viral infections: 'super-antibodies' enter the fray.
    Walker LM, Burton DR.
    Nat Rev Immunol; 2018 May 04; 18(5):297-308. PubMed ID: 29379211
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.